UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
Leishmania Vaccine Study

Adults age 18 to 49 who are in overall good health are invited to participate in a study on the safety, tolerability, and effectiveness of a leishmaniasis vaccine.  There are 18 study visits (17 clinic visits and 1 phone call) required over a period of 18 months.  Compensation is provided.

To learn more, call 319-356-4848 or e-mail recruit-vaccine-research@uiowa.edu.

Start Date
February 27, 2013
End Date
August 27, 2013
Gender Preference
Age Group
18 - 49 years
Principal Investigator
Patricia Winokur
Contact Info

Vaccine Research and Education Office 319-356-4848 or recruit-vaccine-research@uiowa.edu

Vaccine ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.